Status:
COMPLETED
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Melanoma
Ovarian Cancer
Eligibility:
All Genders
1+ years
Brief Summary
This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigati...
Detailed Description
Background: * Patients enrolled on CCR clinical protocols may require long term follow-up to assess outcome (e.g., survival) or the effects of prior therapy. * Keeping the primary treatment protocols...
Eligibility Criteria
- ELIGIBILITY CRITERIA:
Patients of any age who were previously enrolled on a CCR protocol.
Not eligible for or unwilling to participate in an active NCI intramural primary research protocol.
CCR investigator decides it is in the best interests of the patient and the CC for the patient to be seen in follow-up visits at the NIH.
Patient or Legally Authorized Representative (LAR)/guardian is able to provide informed consent.
Key Trial Info
Start Date :
September 19 1996
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2023
Estimated Enrollment :
1031 Patients enrolled
Trial Details
Trial ID
NCT00001503
Start Date
September 19 1996
End Date
June 15 2023
Last Update
June 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892